Renaissance Capital logo

MYNZ News

Renaissance Capital’s November IPO Market Update

RIVN

During November, 34 IPOs raised $17.6 billion, the IPO market's biggest November since 1999. Blank check companies continued to gain momentum, as 60 SPACs raised $11.1 billion. The most active sector was technology, which accounted for 11 of the month's IPOs and included a mix of consumer engagement software, cloud storage, and crypto mining. Familiar consumer brands like Hertz,...read more

US IPO Weekly Recap: Allbirds spreads its wings and soars 93% in a 12 IPO week

BIRD

November kicked off with a 12 IPO week and shoe brand Allbirds (BIRD) was at the front of the flock, posting a first-day pop of 93%. 23 SPACs also went public. New issuers continued to join the pipeline, with five IPOs and 13 SPACs submitting initial filings. Two issuers postponed this past week: Russian car-sharing firm Delimobil (DMOB) and...read more

German micro-cap Mainz Biomed prices US IPO at $5 midpoint

MYNZ

Mainz Biomed, which is commercializing in vitro molecular tests for cancer screening, raised $10 million by offering 2 million shares at $5, within the range of $4 to $6. Mainz Biomed is a molecular genetics cancer diagnostic company formed in 2021 to acquire PharmGenomics with the purpose of commercializing its product portfolio in Europe and the US. PharmGenomics is a...read more

US IPO Weekly Recap: DevOps platform GitLab leads a 7 IPO week

GTLB

The IPO market remained active this past week as seven IPOs raised $2.1 billion. SPAC activity kept steady with 10 blank check IPOs raising $1.6 billion. New filers continued to pour into the IPO pipeline, with 12 IPOs and nine SPACs submitting initial filings. Software development platform GitLab (GTLB) priced above the upwardly revised range to raise $801...read more